U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188131188131NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV TransmissionCompletedHas ResultsHIV InfectionsDrug: Emtricitabine|Drug: Emtricitabine/Tenofovir disoproxil fumarate|Drug: Lopinavir/Ritonavir|Drug: Nevirapine|Drug: Tenofovir disoproxil fumaratehttps://ClinicalTrials.gov/show/NCT00089505
188132188132A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Optimized Background ARVs|Drug: enfuvirtide [Fuzeon]|Drug: enfuvirtide [Fuzeon]https://ClinicalTrials.gov/show/NCT00089492
188133188133A Study of Xeloda (Capecitabine) in Women With High-Risk Breast CancerCompletedHas ResultsBreast CancerDrug: capecitabine [Xeloda]|Drug: Taxotere|Drug: Taxoterehttps://ClinicalTrials.gov/show/NCT00089479
188134188134Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: AMD11070https://ClinicalTrials.gov/show/NCT00089466
188135188135Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell TransplantCompletedNo Results AvailableMultiple MyelomaDrug: Dexamethasone|Drug: Cyclophosphamide|Drug: Melphalan|Drug: Fludarabine|Drug: Bortezomide|Procedure: Leukapheresis|Drug: Interleukin|Procedure: Infusion #1|Procedure: Leukapheresis #2|Procedure: Infusion #2|Procedure: Auto Grafthttps://ClinicalTrials.gov/show/NCT00089453
188136188136Assessment of Interactions Between Methamphetamine and Aripiprazole - 1Active, not recruitingNo Results AvailableAmphetamine-Related DisordersDrug: Aripiprazolehttps://ClinicalTrials.gov/show/NCT00089440
188137188137IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant GliomaCompletedNo Results AvailableGlioblastoma Multiforme|Anaplastic Astrocytoma|OligoastrocytomaDrug: IL13-PE38QQR|Procedure: Surgery for placement|Procedure: Radiation therapy|Drug: Temozolomide with radiation therapyhttps://ClinicalTrials.gov/show/NCT00089427
188138188138Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral ContraceptivesCompletedNo Results AvailablePremenstrual Syndrome|PMS|Premenstrual Dysphoric Disorder|PMDD|DepressionDrug: CDB 2914https://ClinicalTrials.gov/show/NCT00089414
188139188139Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the LiverCompletedNo Results AvailableColorectal Cancer|Metastatic CancerDrug: isolated perfusion|Drug: melphalan|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00089401
188140188140Cilengitide in Treating Patients With Acute Myeloid LeukemiaTerminatedNo Results AvailableAdult Acute Basophilic Leukemia|Adult Acute Eosinophilic Leukemia|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult AcuteDrug: cilengitidehttps://ClinicalTrials.gov/show/NCT00089388
188141188141Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNo Results AvailableMale Breast Cancer|Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Basal Cell Carcinoma of the Lip|Recurrent Breast Cancer|Recurrent Colon Cancer|Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Recurrent Gastric CanDrug: alvespimycin hydrochloride|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00089362
188142188142Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic LeukemiaCompletedNo Results AvailableRecurrent Childhood Acute Lymphoblastic LeukemiaBiological: alemtuzumab|Drug: methotrexate|Drug: mercaptopurinehttps://ClinicalTrials.gov/show/NCT00089349
188143188143Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast CancerActive, not recruitingNo Results AvailableBreast CancerProcedure: Bone Marrow Aspirationhttps://ClinicalTrials.gov/show/NCT00089323
188144188144Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerRadiation: technetium-99https://ClinicalTrials.gov/show/NCT00089310
188145188145Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck CancerCompletedHas ResultsHead and Neck CancerBiological: Cetuximab|Drug: Carboplatin|Drug: Paclitaxel|Radiation: Radiation therapyhttps://ClinicalTrials.gov/show/NCT00089297
188146188146Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHLActive, not recruitingNo Results AvailableNon-Hodgkin's Lymphoma (NHL)Drug: Rituxan|Drug: motexafin gadolinium|Drug: 111Indium-Zevalin and 90Yttrium-Zevalinhttps://ClinicalTrials.gov/show/NCT00089284
18814718814717-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or LymphomasCompletedNo Results AvailableAnaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult DiffuDrug: alvespimycin hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00089271
188148188148Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous TreatmentCompletedNo Results AvailableNeuroblastomaBiological: beta-glucan|Biological: monoclonal antibody 3F8|Biological: sargramostim|Drug: isotretinoinhttps://ClinicalTrials.gov/show/NCT00089258
188149188149Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal CancerRecruitingNo Results AvailableBrain and Central Nervous System Tumors|Neuroblastoma|SarcomaRadiation: iodine I 131 monoclonal antibody 8H9https://ClinicalTrials.gov/show/NCT00089245
188150188150Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV MelanomaCompletedNo Results AvailableIntraocular Melanoma|Melanoma (Skin)Biological: IFA|Biological: 6MHP|Biological: GM-CSFhttps://ClinicalTrials.gov/show/NCT00089219
188151188151Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNo Results AvailableIntraocular Melanoma|Melanoma (Skin)Biological: incomplete Freund's adjuvant|Biological: multi-epitope melanoma peptide vaccine|Biological: sargramostimhttps://ClinicalTrials.gov/show/NCT00089206
188152188152Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: incomplete Freund's adjuvant|Biological: multi-epitope melanoma peptide vaccine|Biological: sargramostimhttps://ClinicalTrials.gov/show/NCT00089193
188153188153T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney TransplantCompletedNo Results AvailableActinic Keratosis|Basal Cell Carcinoma of the Skin|Recurrent Skin Cancer|Squamous Cell Carcinoma of the SkinDrug: liposomal T4N5 lotion|Other: placebo|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00089180
188154188154Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic AmyloidosisCompletedNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmBiological: filgrastim|Drug: dexamethasone|Drug: melphalan|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00089167
188155188155Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNo Results AvailableNoncontiguous Stage II Small Lymphocytic Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Stage III Small Lymphocytic Lymphoma|Stage IV Small Lymphocytic LymphomaBiological: apolizumab|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00089154
188156188156Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)TerminatedHas ResultsCancerDrug: mycophenolate mofetil|Drug: placebohttps://ClinicalTrials.gov/show/NCT00089141
188157188157Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder CancerCompletedNo Results AvailableBladder CancerDrug: gemcitabine hydrochloride|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00089128
188158188158Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's LymphomaTerminatedNo Results AvailableLymphomaBiological: autologous immunoglobulin idiotype-KLH conjugate vaccine|Biological: rituximab|Biological: sargramostimhttps://ClinicalTrials.gov/show/NCT00089115
188159188159Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney CancerCompletedNo Results AvailableKidney CancerDrug: gemcitabine hydrochloride|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00089102
188160188160Decitabine in Treating Patients With Advanced Refractory Solid Tumors or LymphomasTerminatedNo Results AvailableHematopoietic/Lymphoid Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: decitabine|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00089089

* Görseller ve İçerik tekif hakkına sahip olabilir